4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-24-001995
SVP, Chief Legal Officer sold 7,411 shares at $1.52 ($11,265)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hadas Nicole R. · SVP, Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-27 | Sale : show line 1 in the form 10b5-1 | −7,411 | $1.52 | $11,265 | 669,233 | D |
| Open-market sales · 7,411 sh · avg $1.52 · $11,265 | ||||||
Loading xslF345X05/primarydocument.xml…